Clinical Trials Browser

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Autoimmune Diseases, Multiple Sclerosis, Myasthenia Gravis, Myositis, Neuromyelitis Optica, POEMS Syndrome, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

NCT06532643 2024-09-19

Safety and Efficacy of Anti-CD20/CD30 CAR-T Cells in Subjects with Relapsed/Refractory Lymphoma

Phase EARLY_PHASE1 Recruiting

9 enrolled

Lymphoid

Lymphoma

NCT06224049 2024-03-12

GI-hNeoT-01

Phase EARLY_PHASE1 Recruiting

6 enrolled

Lymphoid

Lymphoma, T-Cell, Epstein-Barr Virus Infections

Clinical Trials

A Pilot "Window-3" Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Patients With Previously Untreated High-risk Mantle Cell Lymphoma

CAR 70-BCMA CAR-T Cells for the Treatment of Relapsed or Refractory Plasma Cell Neoplasms

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation

CAR BCMA-70 CAR-T Cells for the Treatment of High-risk Plasma Cell Neoplasms

TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors

TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors

TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC

UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML

Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma

UTAA09 Injection in the Treatment of Relapsed/Refractory Hematolymphatic Malignancies.

Anti-CD19-CAR-T Cells in Subjects With Relapsed/Refractory B Cell Malignancies

Allogeneic B7H3 CAR-γδT Cell Therapy for Advanced Solid Tumors

A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy

SN301A

Allogeneic CD19-targeted CAR-γδT Cell Infusion Therapy in Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia

NEXTGENTIL-ACT

CARTinNS

Safety and Efficacy of Anti-CD20/CD30 CAR-T Cells in Subjects with Relapsed/Refractory Lymphoma

GI-hNeoT-01

EBV CAR-T Cells for Nasopharyngeal Carcinoma

BGT007 Cell Treatment of Nasopharyngeal Carcinoma

TIL Cells for the Treatment of the Advanced Solid Tumors Patients

TCR-T Cells for the Treatment NY-ESO-1-positive Advanced Solid Tumors

B7-H3 Targeting CAR-T Cells Therapy for B7-H3 Positive Solid Tumors

Study of Anti-PSMA CAR NK Cell (TABP EIC) in Metastatic Castration-Resistant Prostate Cancer

Anti-BCMA CAR-NK Cell Therapy for the Relapsed or Refractory Multiple Myeloma

BCMA Chimeric Antigen Receptor Expressing T Cells Therapy for Relapsed/Refractory Multiple Myeloma

Dual CD33-CLL1-CAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

The Fourth Generation CART-cell Therapy for Refractory-Relapsed Ovarian Cancer

Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic Malignancies

Haploidentical Stem Cell Transplantation in Neuroblastoma

Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation

CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma

CAR-T for Children With Relapsed and Refractory Acute Lymphoblastic Leukemia

Anti-CD19 U-CAR-T Cell Therapy for B Cell Hematologic Malignancies

MESO-CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer

A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors

Allogeneic Stem Cell Transplantation for Patients With Multiple Myeloma